These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20690129)

  • 1. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population.
    Hobson VL; Hall JR; Harvey M; Cullum CM; Lacritz L; Massman PJ; Waring SC; O'Bryant SE
    Int J Geriatr Psychiatry; 2011 Apr; 26(4):351-5. PubMed ID: 20690129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston naming test short forms: a comparison of previous forms with new item response theory based forms.
    Graves RE; Bezeau SC; Fogarty J; Blair R
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):891-902. PubMed ID: 15742540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years.
    Tombaugh TN; Hubley AM
    J Clin Exp Neuropsychol; 1997 Dec; 19(6):922-32. PubMed ID: 9524887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease].
    Serrano C; Allegri RF; Drake M; Butman J; Harris P; Nagle C; Ranalli C
    Rev Neurol; 2001 Oct 1-15; 33(7):624-7. PubMed ID: 11784949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Odd/Even short forms of the Boston Naming Test: preliminary geriatric norms.
    Fisher NJ; Tierney MC; Snow WG; Szalai JP
    Clin Neuropsychol; 1999 Aug; 13(3):359-64. PubMed ID: 10726606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia does not explain correlation between age and scores on Boston Naming Test.
    Mackay A; Connor LT; Storandt M
    Arch Clin Neuropsychol; 2005 Jan; 20(1):129-33. PubMed ID: 15620819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of the effects of age, education, and gender on the Boston Naming Test.
    Zec RF; Burkett NR; Markwell SJ; Larsen DL
    Clin Neuropsychol; 2007 Jul; 21(4):587-616. PubMed ID: 17613980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of an incidental memory modification of the Boston Naming Test (memo-BNT) in differentiating between normal aging and mild Alzheimer's disease.
    Karrasch M; Myllyniemi A; Latvasalo L; Söderholm C; Ellfolk U; Laine M
    Clin Neuropsychol; 2010 Nov; 24(8):1355-64. PubMed ID: 20967687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boston Naming Test: shortened versions for use in Alzheimer's disease.
    Mack WJ; Freed DM; Williams BW; Henderson VW
    J Gerontol; 1992 May; 47(3):P154-8. PubMed ID: 1573197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Rev Neurol (Paris); 2010; 166(6-7):584-93. PubMed ID: 20226490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-Mental Status Examination: mixed Rasch model item analysis derived two different cognitive dimensions of the MMSE.
    Schultz-Larsen K; Kreiner S; Lomholt RK
    J Clin Epidemiol; 2007 Mar; 60(3):268-79. PubMed ID: 17292021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?
    Balthazar ML; Cendes F; Damasceno BP
    Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Boston Naming Test in Swedish: normative data.
    Tallberg IM
    Brain Lang; 2005 Jul; 94(1):19-31. PubMed ID: 15896380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boston Naming Test in Alzheimer's disease.
    Williams BW; Mack W; Henderson VW
    Neuropsychologia; 1989; 27(8):1073-9. PubMed ID: 2797414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative data on the Boston Naming Test and two equivalent 30-item short forms.
    Saxton J; Ratcliff G; Munro CA; Coffey EC; Becker JT; Fried L; Kuller L
    Clin Neuropsychol; 2000 Nov; 14(4):526-34. PubMed ID: 11262721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the Boston Naming Test and multiple-occasion normative data for older adults on 15-item versions.
    Kent PS; Luszcz MA
    Clin Neuropsychol; 2002 Dec; 16(4):555-74. PubMed ID: 12822064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.